BACKGROUND: Artificial neural networks (ANNs) are nonlinear pattern recognition techniques that can be used as a tool in medical decision making. The objective of this study was to develop an ANN model for predicting survival in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: A flexible nonlinear survival model based on ANNs was designed by using clinical and histopathological data from 84 patients who underwent resection for PDAC. RESULTS: Seven of 33 potential risk variables were selected to construct the ANN, including lymph node metastasis, differentiation, body mass index, age, resection margin status, peritumoral inflammation, and American Society of Anesthesiologists grade. Three variables (ie, lymph node metastasis, leukocyte count, and tumor location) were significant according to Cox regression analysis. Harrell's concordance index for the ANN model was .79, and for Cox regression it was .67. CONCLUSIONS: For the first time, ANNs have been used to successfully predict individual long-term survival for patients after radical surgery for PDAC.
BACKGROUND: Artificial neural networks (ANNs) are nonlinear pattern recognition techniques that can be used as a tool in medical decision making. The objective of this study was to develop an ANN model for predicting survival in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: A flexible nonlinear survival model based on ANNs was designed by using clinical and histopathological data from 84 patients who underwent resection for PDAC. RESULTS: Seven of 33 potential risk variables were selected to construct the ANN, including lymph node metastasis, differentiation, body mass index, age, resection margin status, peritumoral inflammation, and American Society of Anesthesiologists grade. Three variables (ie, lymph node metastasis, leukocyte count, and tumor location) were significant according to Cox regression analysis. Harrell's concordance index for the ANN model was .79, and for Cox regression it was .67. CONCLUSIONS: For the first time, ANNs have been used to successfully predict individual long-term survival for patients after radical surgery for PDAC.
Authors: Alan Karthikesalingam; Omneya Attallah; Xianghong Ma; Sandeep Singh Bahia; Luke Thompson; Alberto Vidal-Diez; Edward C Choke; Matt J Bown; Robert D Sayers; Matt M Thompson; Peter J Holt Journal: PLoS One Date: 2015-07-15 Impact factor: 3.240
Authors: Julio Montes-Torres; José Luis Subirats; Nuria Ribelles; Daniel Urda; Leonardo Franco; Emilio Alba; José Manuel Jerez Journal: PLoS One Date: 2016-08-17 Impact factor: 3.240